PACE-LUNG (#1368)
Laufzeit: 01.01.2021 - 31.12.2040
imported
Kurzfassung
Additional chemotherapy for EGFRm patients with the continued presence of plasma ctDNA EGFRm at week 3 after start of osimertinib 1st -line treatment (PACE)
